These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention. Ballinger A, Smith G. Expert Opin Pharmacother; 2001 Jan; 2(1):31-40. PubMed ID: 11336566 [Abstract] [Full Text] [Related]
28. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Pajdo R, Drozdowicz D, Ptak A, Hahn EG. Microsc Res Tech; 2001 Jun 01; 53(5):343-53. PubMed ID: 11376495 [Abstract] [Full Text] [Related]
29. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Weir MR, Sperling RS, Reicin A, Gertz BJ. Am Heart J; 2003 Oct 01; 146(4):591-604. PubMed ID: 14564311 [Abstract] [Full Text] [Related]
30. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Strand V. Lancet; 2007 Dec 22; 370(9605):2138-51. PubMed ID: 18156036 [Abstract] [Full Text] [Related]
31. Gastrointestinal safety of coxibs and outcomes studies: what's the verdict? Laine L. J Pain Symptom Manage; 2002 Apr 22; 23(4 Suppl):S5-10; discussion S11-4. PubMed ID: 11992743 [Abstract] [Full Text] [Related]
32. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs]. László A. Orv Hetil; 2002 Jul 07; 143(27):1643-8. PubMed ID: 12180001 [Abstract] [Full Text] [Related]
33. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications. Pascucci RA. J Am Osteopath Assoc; 2002 Sep 07; 102(9):487-9. PubMed ID: 12361181 [Abstract] [Full Text] [Related]
35. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer. Yamamoto DS, Viale PH. Clin J Oncol Nurs; 2003 Sep 07; 7(1):21-9. PubMed ID: 12629931 [Abstract] [Full Text] [Related]
37. [Non-steroidal antiinflammatory drug--management of gastrointestinal complications and inhibition of COX-2]. Tada Y, Nagasawa K. Nihon Rinsho; 1999 Feb 07; 57(2):419-24. PubMed ID: 10078017 [Abstract] [Full Text] [Related]
38. COX-2 inhibitors. What is their place? McGettigan P. Aust Fam Physician; 2000 Sep 07; 29(9):847-52. PubMed ID: 11008387 [Abstract] [Full Text] [Related]
39. Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis. Bae SC, Corzillius M, Kuntz KM, Liang MH. Rheumatology (Oxford); 2003 Jan 07; 42(1):46-53. PubMed ID: 12509612 [Abstract] [Full Text] [Related]
40. Clinical pharmacology of selective COX-2 inhibitors. Capone ML, Tacconelli S, Sciulli MG, Patrignani P. Int J Immunopathol Pharmacol; 2003 Jan 07; 16(2 Suppl):49-58. PubMed ID: 14552704 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]